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Counting Us In: Problems and Opportunities in 
Health Research on Transgender and Gender- 
Nonconforming Communities 
Christoph Hanssmann1 
INTRODUCTION 
In the last decade, the emergence into the public consciousness of 
transgender as an identity and as a field of study has had a profound impact 
on individuals who claim, or are incorporated in some way, by the term 
“transgender.” This shift has resulted in an increase in the degree to which 
public health research incorporates questions about transgender health. The 
past several years have seen a rise in the number of epidemiological studies 
and reviews concerning transgender individuals.2 These findings are being 
taken up in the work of activists and policymakers. While this may be 
considered a success in terms of gaining empirical evidence to ground 
claims for increased access to health and social services and to support 
initiatives that reduce health disparities among transgender and gender-
nonconforming individuals, it may also carry a number of problematic 
implications. 
This article examines the context of the emergence of increased demands 
for trans health research and practice and argues that simple inclusion in 
most existing frameworks of health research and biomedicine will not yield 
a broadly effective result. Health research in other marginalized health-
based projects, such as HIV/AIDS research in gay men’s health, has taken 
some missteps that we may take care to avoid in navigating a path that is 
more constructive and efficacious for the health and wellbeing of trans 
gender-nonconforming populations. Doing so necessitates a critique of the 
following: the professionalization of trans health advocacy in the context of 
social movements’ incorporation by nonprofits; a critique of state-based 
542 SEATTLE JOURNAL FOR SOCIAL JUSTICE 
TRANSGENDER ISSUES AND THE LAW 
violence and its effect on health outcomes, as well as the relationship of 
health research to state projects to increase criminalization and surveillance; 
and a critical examination of the role of health research and advocacy in 
reifying narrow identity categories that erase the complex experiences and 
multiple vectors of oppression faced by trans populations.  
This article will explore several questions in an effort to shed light on 
areas of tension and ambivalence with regard to transgender inclusion in 
health research:  
1. In what ways do the foci of epidemiological studies (frequently, the 
risk of violence or HIV infection) frame the ways these studies are 
discussed and used as a basis for action?  
2. What is the significance of including transgender individuals in 
health research, and what is at stake in doing so?  
3. How does the category of “transgender,” as it is mobilized in 
epidemiological research, obscure and complicate issues relating to 
other factors of marginalization and social determinants of health?  
4. How do epidemiological data and inclusion, or exclusion from health 
research in general, “loop back”3 to affect transgender people’s 
concepts of themselves as individuals and as members of trans 
communities? 
While there is much articulated resistance in transgender and gender-
nonconforming communities to the pathologizing research that dominated 
in the past,4 there is palpable enthusiasm for more current models of health 
research in general and epidemiological and pharmacological health 
research in particular. The reasons for this support are many and are 
generally quite valid. For example, some transgender and gender-
nonconforming people pursue specific medical interventions that have not 
been well evaluated with regard to efficacy and potential risks.5 
Additionally, groups involved in trans activism and advocacy, as well those 
involved in research, have grown in number and scope. Now that we may, 
in some instances, influence research agendas, can we not drive their 
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direction in ways that will be supportive of our communities and of our 
health and wellbeing? 
I begin this article with an assumption that trans health is important and 
valid, that all transgender and gender-nonconforming people are entitled to 
exceptional healthcare that offers access to good health to whatever extent 
possible inclusive of gender-confirming and supportive care, and that none 
of us should encounter barriers to primary or specialty medical care that we 
require. Additionally, I assume that health research, in general, is an 
important pursuit that transgender and gender-nonconforming people can 
benefit from. However, I also intend to issue certain cautions about how this 
research is pursued and positioned, and I warn that this work must be 
organized in such a way as to attend to the lopsided distribution of benefits 
and uneven vulnerability on the part of certain populations of trans people, 
such as trans people of color and poor trans people, rather than focus only 
on certain sectors of these communities with greater relative privilege. 
I. SHIFTS IN APPROACH: HEALTH RESEARCH ON TRANS AND LGBTQ 
COMMUNITIES 
In the past several years, there has been a marked increase in the number 
of epidemiologic and other health research studies that concern transgender 
individuals.6 Many of these studies differ significantly in content and 
approach from medical studies of transsexuals7 conducted in the early- to 
mid-twentieth century.8 In general, the literature on transgender health that 
is currently available focuses on health disparities, disease prevalence and 
incidence, and particular associations of trans identity with negative health 
outcomes (such as experience of violence). This contrasts with earlier 
studies that explored the etiology of transsexuality itself, and its relationship 
to, or overlap with, homosexuality.9 In other words, these studies have 
shifted from focusing on a disease to focusing on a community. 
As far as we know, these earlier studies were conducted strictly by non-
trans psychiatrists, sexologists, and physicians. In contrast, one feature of 
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this new wave of trans health research is that in some cases, transgender or 
gender-nonconforming individuals are directly involved in the design, 
implementation, and dissemination of these studies.10 Many serve as 
principal investigators, researchers, and medical doctors. To a growing 
degree, trans individuals are seen as experts within our own communities.11 
A. Trans Health in the Context of LGBTQ Health Advocacy 
LGBTQ health has recently taken shape as a unique form of health 
activism within the United States. Trans health advocacy has emerged as a 
distinctly marginal aspect of this project. While at times it has claimed 
distinct needs,12 trans health advocacy is frequently subsumed within 
“LGBTQ health.”13 As Steven Epstein has noted, LGBTQ health advocacy 
initially took shape within grassroots activism. Its origins were in the 
feminist women’s health movement and in the approaches that the group 
ACT UP (a radical grassroots group formed in response to the AIDS crisis) 
initially took in targeting federal biomedical institutions.14 Early LGBTQ 
health activism targeted pervasive homophobia in clinical settings and the 
lack of attention political leaders gave to the effect of AIDS on LGBTQ 
communities. Gradually, as activists gained greater membership as what 
Epstein calls “lay experts” and “treatment activists,” (or activists who 
gained knowledge about biomedical research for the purpose of influencing 
the decisions of researchers and other powerful stakeholders)  and as 
increased resources were earmarked for pharmacological and health 
research on HIV/AIDS, objectives shifted.15 
Epstein discusses some of the tactics of grassroots community-based 
health activism of the early 1990s, including the formation of locally-based 
organizations dedicated to service provision, education, and prevention and 
engagement in militant direction action projects, street activism and self-
education.  He traces several departures from these tactics toward a state-
based focus on improving the health status of LGBTQ communities.16 Calls 
to national membership organizations—like the Gay and Lesbian Task 
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Force—to adopt an LGBTQ health agenda as well as greater involvement of 
lesbians in cancer prevention and research—breast cancer, in particular, as 
an area of interest—with special focus on groups like the National Cancer 
Institute, are both examples of state-based health activism.17 In addition, he 
notes, LGBTQ physicians began to rally for shifts from within the medical 
establishment. First formed as the American Association for Physicians for 
Human Rights, this group was later renamed the Gay and Lesbian Medical 
Association (GLMA).18 In 1996, GLMA added bisexual and transgender 
health to its list of concerns.19 
In this shift to state-based health activism, the focus on LGBTQ health 
moved from community-based concerns about homophobia in clinical 
settings to broader health disparities,20 with particular attention to the 
increased burden of disease and disease risk (AIDS/HIV, cancer, tobacco 
use, cardiovascular disease, and a variety of others) in these communities 
when compared to other social groups.21 Concurring with this change in 
focus was a change in agenda: broad epidemiologic research became a 
primary objective of LGBTQ health activism.22 This was seen as important 
both in empirically establishing widespread health disparities and in the 
resulting evidence being available for use in leveraging resources to 
cultivate health and prevent disease in these communities.23 
With this shift in LGBTQ health has come some degree of incorporation 
and institutionalization within national health research agendas. For 
example, GLMA published a compendium to the report, Healthy People 
2010, which focused on LGBTQ health disparities and areas for continued 
research.24 In 1998 and 1999, the American Public Health association 
passed two resolutions calling for increased inclusion of LGBTQ people (in 
1998) and transgender individuals in particular (in 1999) in health 
research.25 
While transgender communities are included in this work, our needs and 
concerns are frequently sidelined, particularly as it becomes more broadly 
institutionalized. Federal officials, it is assumed, find categories such as 
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transgender “too ‘out there,’”26 and resist making changes to entrenched 
methods of data gathering, such as including demographic options that are 
not restricted to male or female.27 This parallels some of the ways that trans 
communities have been left out of a variety of state-based initiatives. For 
example, the Employment Non-Discrimination Act (ENDA) is a federal 
legislative bill that seeks to protect employees from being fired on the basis 
of sexual orientation or gender identity (the latter of which was only added 
to the bill’s language in 2007, after its initial introduction in 1994).28 In 
2007, the year the bill was passed by the House, “gender identity” was 
eliminated for fear that it would not pass if it protected more than just 
sexual orientation.29 
Trans and LGBTQ movements are often closely tied, “in part because 
United States culture often conflates sexual orientation and gender 
expression, and in part because of a long history of sexual and gender 
outsiders finding community together, resisting oppression together, and 
often understanding their identities through and against each other.”30 
There is some ambivalence about the relationship between emerging 
trans struggles and LGBTQ activism, particularly mainstream advocacy 
projects that are characterized by the pursuit of state inclusion such as gay 
marriage and participation in the military. Trans and gender-nonconforming 
people face concerns that differ somewhat from the concerns faced by 
gender-conforming LGBTQ people. These unique concerns, combined with 
the hesitancy of state-based projects to include transgender and gender-
nonconforming people, have caused trans activists and advocates to pursue 
trans-specific research and initiatives. 
B. Trans Health Advocacy as a Unique Pursuit 
As trans health advocacy emerges as a pursuit separate and unique from 
LGBTQ health advocacy, individuals in trans communities are increasingly 
calling for more health research, regardless of the barriers to inclusion 
within broad-based federal research programs. For some, this is noteworthy 
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because it indicates a shift away from distrust of the biomedical 
establishment, which continues to play a particularly insidious role in the 
lives of many trans individuals, exercising coercive and rigorous gate-
keeping practices in managing patients’ gender transitions, and acting as an 
authority in establishing trans identities as strictly medicalized. Much trans 
activism is based in a critique of medicalization because:  
1. Physicians are seen as the ultimate authority on a person’s 
gender identity, above and beyond a person’s self-identification 
2. The pathologization of the category of trans stabilizes non-trans 
identity as non-pathological 
3. Other vectors of oppression, such as class, race, age and ability 
figure into basic health care access, the lack of which may have 
negative implications in healthcare providers making diagnoses 
concerning trans identity 
4. The law has incorporated a medicalized model of trans identity 
that affects trans people’s ability to obtain essential legal 
documents, such as identification, unless they have “proof” of 
medically-validated trans identity.  
However, it is possible that the earlier described shift of transgender and 
gender-nonconforming people taking a greater role in medicine and 
health research has made biomedicine more responsive, in limited 
instances, to the needs of these communities. 
1. Specific Issues Related to Trans Health Research 
Similar to LGBTQ health activism, calls for trans health research focus 
on exploring the existence and pervasiveness of health disparities among 
transgender and gender-nonconforming communities.31 This is necessary to 
gain a better understanding of how to mitigate the effects of these inequities 
and to build broader and more effective interventions to meet these goals. 
However, there are several reasons that trans health distinguishes itself 
from LGBQ health advocacy and investigates disparities through the lens of 
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trans identity specifically. Epidemiologic research may focus on some 
similar health outcomes and disproportionate disease burden,32 but 
researchers assume that risk factors differ in various ways. In addition, 
some transgender and gender-nonconforming health advocates are 
interested in health research that departs from concerns of gender-
conforming LGBQ populations. For example, some transgender and 
gender-nonconforming individuals may pursue gender-confirming medical 
interventions, such as hormone treatment or surgeries, and these require 
both specific research and clinical competencies.33 Last, the medical 
profession views transgender as a “condition” or a clinical diagnosis in 
ways that are not the case with regard to sexual orientation.34 This 
contextualizes and positions trans health activism and research in ways that 
differ from how LGBQ health activism has positioned itself.  
For example, in contrast to non-trans-LGBQ communities, there is great 
interest in pharmacological research on the long-term effects of 
masculinizing or feminizing hormones,35 although I will not explore this 
topic in-depth in the context of this article. This topic merits its own 
exploration of the economies of pharmaceutical research and marginalized 
populations in the context of biomedicine. There is also a great deal of 
interest in incidence and prevalence of HIV/AIDS in transgender and 
gender-nonconforming populations, particularly given the recent high rates 
that have been documented among trans women in metropolitan areas.36 
These and other issues illustrate the ways in which trans health advocacy is 
concerned with the potential differences in risk factors and health outcomes 
that  set it apart from LGBQ health advocacy in general. 
2. Trans health Research: How LGBTQ Health Advocacy Shaped 
Priorities 
a) Topical and Methodological Foci 
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Despite some of the ways trans health activism and research has become 
distinct from LGBTQ health advocacy, it carries vestiges of its growth from 
within this context. Trans health research agendas have been articulated 
from a variety of contexts, ranging from state-based37 to community-
engaged.38 It is important to consider how these distinct agendas emerged 
and what the consequences are of following the state-based research 
trajectories of LGBTQ health advocacy, both of which I will attend to in the 
next section. In the context of this article, “state-based” strategies are those 
that aim to improve population health outcomes spanning broad and 
geographically dispersed groups of people. Strategies may be in the form of 
federal programs, legislation, state mandates, large-set data collection and 
quantitative analysis, and so on. “Community-based” strategies, in contrast, 
are generally local to smaller geographic areas and population subsets. 
These may be smaller-scale policy-based projects, targeted interventions, or 
research focusing on more in-depth data collection and/or smaller or more 
specific datasets.  
It is likely that some of the focus on HIV/AIDS as a trans health issue 
emerged in part because of trans health originating in part from LGBTQ 
health advocacy more broadly. From within state funded and administered 
research programs in the area of HIV/AIDS, the issue of disproportionate 
disease burden for trans people emerged.39 However, the Centers for 
Disease Control (CDC), the primary federal body in charge of disease 
surveillance in the United States, failed in their epidemiologic data 
gathering to distinguish between “men who have sex with men” (MSM) and 
trans women who have sex with men, lumping both groups into the MSM 
category.40 Thus, HIV/AIDS as a trans health concern was subsumed within 
gay and bisexual men’s health. Notably, trans men who have sex with other 
men (trans or non-trans) did not specifically figure into data collection as 
MSM.  
Noting this error in conceptual conflation on the part of the CDC, some 
researchers and trans health activists set out to establish disparities in health 
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outcomes with regard to HIV/AIDS incidence and prevalence rates as 
distinct from patterns in gay and bisexual non-trans men (or MSM more 
broadly).41 Disease incidence and prevalence patterns are also linked to 
funding allotment for prevention efforts, and given researchers’ assertions 
that funding streams directed towards prevention efforts for MSM do not 
address the needs of transgender individuals,42 activists and researchers 
prioritized establishing a body of data to demonstrate HIV/AIDS as a 
specific issue within trans communities. 
This paved the way for a variety of small-scale epidemiologic studies to 
track HIV incidence and prevalence rates in trans communities. These 
concerned trans women, though more recent studies have also investigated 
HIV/AIDS incidence and prevalence, as well as risk factors, among trans 
masculine individuals.43 
Some of these studies were conducted in collaboration with transgender 
and gender-nonconforming communities.44 Community-based participatory 
health methods, which I will discuss in more detail later in the article, also 
use epidemiologic approaches to gathering information about disease 
burden in communities. However, they do so in a way that puts stake in 
local and community knowledge about context and underlying causes. 
These projects engage academically unaffiliated community members in the 
process of developing and advancing topics to pursue in health research.45 
In general, community-based studies have tended to undertake multi-
layered investigations of HIV/AIDS incidence and prevalence as one of 
many factors affecting trans health and its occurrence in the context of other 
factors affecting health (e.g., lack of access to employment or housing 
leading to survival sex work). 
This approach contrasts with traditional research methods that assume 
scientific experts are best positioned to discern the reasons for disease and 
to design interventions for prevention. While most HIV/AIDS and health 
research has taken a traditional approach, notable exceptions have produced 
nuanced understandings of health inequities in trans and gender-
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nonconforming communities and rich descriptions of the context in which 
these occur. They also focus on some of the important differences among 
individuals within trans communities and how these make a difference in 
health outcome. 
In some ways, research on HIV/AIDS in trans communities has seen an 
overlapping of state-based agendas with community-based research. 
Researchers with the former orientation have used traditional epidemiologic 
data gathering that has emerged from national surveillance programs to a 
similar end—to secure funding and design interventions. Researchers with 
the latter orientation have employed different methods but with a similar 
topical focus on HIV/AIDS, which initially emerged and gained momentum 
from state-based research agendas. This tension highlights some of the 
broader questions about trans health in relation to LGBTQ health: how does 
trans health go about articulating a different approach to health research and 
also begin to develop its own complex topical foci when its history is so 
intertwined with that of LGBTQ health? What might we learn from the 
direction of LGBTQ health advocacy? 
b) Funding Structure, Professionalization, and the Turn Away from 
Community-Based Work 
The relationship between movements and funding is important when 
considering the factors that frame health research and the disparities to 
leverage funding. Nonprofit agencies and nongovernmental agencies have, 
in the past several decades, grown to supplant the previous role of state-
based public benefits programs that grew from the New Deal.46 Named the 
“shadow state” by Jennifer Wolch,47 this move has created the context for a 
shift in the realm of activism into what many critics have called the 
“nonprofit industrial complex.”48 This has been the source of many fissures 
within activist communities and has been criticized in particular for its 
move towards professionalization and its turn away from grassroots models 
of activism.49 One problematic feature of this transition in activism is the 
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degree to which the viability of projects is linked to palatability. This link is 
evaluated by private and governmental funders, rather than the urgency or 
priority determined by affected members of the communities the projects 
are designed to serve.50 
 Similar to Epstein’s articulation of the shift from a community-based 
LGBTQ health movement to one focused on state-based research agendas, 
mainstream gay and lesbian politics in the past two decades have become 
increasingly focused on state legislative goals over grassroots community-
based organizing.51 This move has created a situation, as Manazala and 
Spade outline, of social movements becoming more reliant on corporations 
and on foundations with accumulated wealth, and, through a process of co-
optation, gay and lesbian rights work has tended increasingly towards work 
protecting individual rights of property over collective wellbeing.52 
These trends of professionalization and cooptation have impacted health 
advocacy, causing HIV/AIDS to come to define gay health in the 1980s and 
1990s, much to the detriment of gay health advocates in establishing a 
broad and far-reaching health program.53 
As trans and gender-nonconforming health activists set priorities for trans 
health, it is important to consider some of the ways that issues at a federal 
level may not align directly with the priorities of local trans and gender-
nonconforming communities, particularly since these communities differ 
radically along lines of race, ethnicity, class, nation of origin, immigrant 
status, age, sexual orientation, ability, religion, geographic location, and so 
on. Instead, an expanded focus on community-based health research 
projects may have a greater potential to attend to the particular local needs 
of trans and gender-nonconforming communities, given the disparate and 
differing needs within these populations. Without the capacity for 
complexity, flexibility and geographic specificity allowed by more deeply 
focused and localized research, it is likely that research projects will fix 
upon a less nuanced set of analyses within this population, possibly 
consolidating relative benefit among those with the most relative privilege. 
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II. ACHIEVEMENTS AND CONCESSIONS OF TRANS INCLUSION IN 
HEALTH RESEARCH 
There have been a variety of achievements in recent years related to trans 
inclusion in health activism and research. These include recent (though not 
broadly incorporated) recognition of the need for health insurance coverage 
for trans-specific healthcare treatments and the expansion of trans health as 
an area for investigation within community-based research. However, with 
achievements often come concessions, and I will point out areas where trans 
inclusion in health research could benefit from a thorough examination of 
its goals and a reassessment of some of its current trajectories. 
In 2008, the American Medical Association passed Resolution 122 
entitled “Removing Barriers to Care for Transgender Patients.” It reads, 
“Resolved, that our American Medical Association support public and 
private health insurance coverage for treatment of gender identity disorder 
as recommended by the patient’s physician.”54 While the resolution 
maintains the restrictive and coercive structure that trans and gender-
nonconforming people in the United States must navigate,55 it is a 
significant victory in the effort to reduce barriers to trans healthcare. As 
gender-confirming medical interventions for trans people have remained 
largely uncovered by public benefits programs and private insurance 
companies, those individuals who seek hormone and surgical treatments 
have, barring significant access to wealth, found many of these to be out of 
reach.56 The AMA resolution does nothing to disentangle the complex and 
contradictory network that trans and gender-nonconforming people are 
subject to with regard to legal identification, gender segregated facilities, 
and other sources of anxiety, frustration, and lack of safety.57 However, if 
taken up in medical practice, it may do a great deal to remove an important 
barrier to healthcare for many trans and gender-nonconforming individuals. 
The ultimate effectiveness of the resolution remains to be seen, but it may 
be indicative of the direction in which medical practice is moving. 
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More recent needs-assessment studies have helped increase the body of 
knowledge about trans and gender-nonconforming health concerns and 
needs. These studies are in addition to research studies that focus solely on 
HIV/AIDS incidence and prevalence and are an achievement in establishing 
some of the widespread barriers to health that trans and gender-
nonconforming people regularly encounter.58 These have served both to 
highlight pressing problems and needs within trans and gender-
nonconforming communities, as well as capture data about health status and 
areas for further research within these populations. Most of these studies 
document issues related to employment and housing access, barriers to 
high-quality primary and medical care, and exposure to transphobic 
violence. These findings can help ground claims for improved access to 
health and social services, and document the pervasiveness of barriers to 
health and wellbeing for many individuals. It is likely that these studies 
have played a role in establishing the body of knowledge that set into 
motion broad policy decisions such as the AMA resolution described above. 
In addition, such evidence is currently used to justify the development of 
trans-specific agencies, services, and other community-based projects.59 
Despite these important gains, there remain issues which have not been 
attended to thoroughly in conceiving a model for trans health with the 
potential to transform and support the health and wellbeing of trans and 
gender-nonconforming communities. First, we must exercise caution in how 
we use the term “transgender” as a category, and how it might collapse 
important differences within it. We also must remain cognizant of who 
might be left out in the choice to use this particular term. For example, 
“transgender” is a category that has varying degrees of resonance among 
those incorporated within the term, and identification with the term may 
vary along racial and class lines.60 In addition, people without access to 
race, class, and education privilege are likely to encounter more severe and 
frequent barriers to health than those with greater access. These differences 
may be obscured or attenuated in the context of health research that 
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considers transgender people overall. Gender-nonconforming individuals 
who are not necessarily included as “transgender” (either based on self-
identification or research criteria), but who face similar or related obstacles 
to positive health outcomes, may be excluded from consideration. 
Second, we must consider whether the questions we ask and the answers 
we seek are necessarily shaped by the context in which we ask them. The 
ways in which epidemiologic, health, and pharmacologic research moves 
from a certain set of assumptions about what questions matter—and indeed, 
what knowledge is valuable or useful—works to prioritize certain answers 
and ways of knowing. As Nancy Krieger asserts, epidemiology is, like any 
science, at once objective (using defined, rigorous, and replicable methods 
to assess refutable propositions) and partisan (reflecting underlying values 
and assumptions guiding conceptualization, choice, and analysis of research 
problems).61 
Marj Plumb notes that “what is knowable about a population and its 
health conditions cannot be found solely through quantitative science,” and 
that local knowledges are frequently viewed “by scientists as unreliable, 
biased, and politically motivated.”62 The investment in professionalization, 
expertise, and empirical data at the expense of community-based, local, and 
anecdotal knowledges serves to shift credibility away from local 
knowledge. Although, at this point, some professionals and experts are 
indeed members of trans and gender-nonconforming communities, this 
change has not collapsed divisions in access to various types of privilege 
that separate “experts” from “laypeople.” 
Health research in trans and gender-nonconforming populations takes 
place within this set of tensions. As “transgender” is a provisional, 
contextual, and mutable term to describe identity and experience, it is 
challenging to gather meaningful data using it as a stable analytic category. 
Given the legacy of biomedicine with regard to its frequent 
conceptualizations of gender-nonconformity as pathological, it is crucial to 
consider Krieger’s assertions about the partisan aspects of epidemiology. 
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There is surely valuable information to be gained in and through health 
research in trans and gender-nonconforming populations, However, there 
are a set of underlying values and assumptions that guide choices about how 
research questions are framed, how inclusion and exclusion criteria are 
formulated, what variables should be considered, and what methodologies 
are utilized, and these questions frequently fade into the background. It is 
important that we grapple with these and other important questions as health 
research in trans and gender-nonconforming populations gains momentum. 
In addition, it is vital to remember that rich and valuable information 
(including information about health and wellbeing) is knowable through a 
variety of means separate from health research. 
III. CURRENT TOPICS OF CONSIDERATION IN TRANS HEALTH 
RESEARCH 
How we frame research questions matters, and so does the context from 
which we develop and pursue research agendas. If trans health activists are 
to follow LGBTQ health advocacy from community-based, local health 
activism to state-based research agendas, we are likely to miss asking 
questions that might yield answers that are critical of the state. In addition, 
it is useful to consider the ways in which research findings have been used 
so far and to speculate about how these may be applied in the future—either 
to the benefit or detriment of trans and gender-nonconforming people. Last, 
if we are to ask questions about the health and wellbeing of trans and 
gender-nonconforming people, we must attend to broader issues as well as 
narrow ones: for example, the way that the current structure of the U.S. 
healthcare system creates substantial barriers to trans and gender-
nonconforming people accessing high-quality primary and specialty care. 
Epidemiologic surveillance employs technology to monitor diseases and 
people at the population level, and uses differences between people to 
assess “risk,” or a person’s probability (based on group membership, 
environment, or other measured factors) to encounter or develop ill health.63 
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Trans health research, particularly epidemiologic research, has centered on 
topics that concern data that are broadly incorporated in programs of 
surveillance at the level of cities, counties, states, and nations. These topics 
generally fit within structures of state priorities in population 
management.64 HIV/AIDS incidence and prevalence data and rates of 
interpersonal violence, for example, provide the basis for state 
policymaking about issues ranging from funding allocation to blood 
donation policies65 to patterns of policing and criminal surveillance. 
Therefore, data collection, in establishing a concept of risk based on 
membership in a particular population, is used to support policies that have 
drastic effects on the lives of individuals based solely on their alignment 
with a certain group. However, health research in trans communities has 
conspicuously not paid attention to the state-based causes of disparities in 
health.66 While interpersonal violence is a common topic of study within 
LGBTQ and transgender communities, gender-based violence that occurs in 
state-based institutions like jails and prisons, group homes, the military, 
immigration detention centers, and public benefits offices is rarely 
considered as a factor that is broadly detrimental to the health of trans and 
gender-nonconforming individuals.67 
For example, transgender women of color are frequently profiled and 
targeted for being involved in sex work, and experience routine harassment 
and arrest as a result. Further, gender-segregated detention facilities usually 
result in trans women being placed in men’s facilities, where they are in 
danger of violence and harassment by guards, staff, and other inmates.68 
This inconsistency in considering interpersonal violence outside the 
context of institutional violence is also reflected in the ways policymakers 
and legislators draw on established data on violence. One particularly 
disturbing example is the way in which rates of interpersonal violence have 
been utilized by state apparatuses to advance hate crimes legislation.69 
Critiques of this legislation have centered on the ineffectiveness of these 
strategies in deterring violence. In addition, hate crimes legislation fails to 
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truly correct the problem, due to the expansion of the criminal justice 
system, which criminalizes trans people, particularly those that are already 
marginalized within trans communities, such as trans women of color.70 
Within the context of increased surveillance and criminalization, trans 
communities become even more vulnerable to police violence and 
surveillance. This demonstrates a tendency to address health problems with 
state-based solutions—to understand violence as a crime that ought to be 
punished through incarceration rather than to understand violence as a 
problem related to social inequities that might be dealt with at a community 
level. At a policy level, it demonstrates the ways in which outcome-focused 
health research that fails to attend to social context and broad inequities can 
result in laws and policies that make the same omission. And again, it fails 
to attend to the relationships and parallels between interpersonal and 
institutional violence.  
This pattern of addressing the material results of inequities rather than the 
source of the problem occurs elsewhere in state-based responses to health 
crises. For example, state-based responses to HIV/AIDS acknowledge it as 
a disease with a disproportionate impact on certain marginalized 
communities. However, the focus on disease treatment and management, 
rather than on the causes and context of disproportionate impact, such as 
poverty, unemployment and other forms of inequity in a context of racism, 
classism, sexism, and ableism. Prevention efforts frequently focus on 
behavior, rather than the contexts which give rise to the constraint of 
options for marginalized populations.  
While research has certainly advanced a set of priorities in increasing 
access to primary and specialty healthcare and focused health interventions, 
it has failed to attend to some important issues. One issue is the way in 
which non-coverage of gender-confirming medical interventions for trans 
people is largely tied to the structure of the U.S. health system, comprised 
primarily of private, employer-based health coverage. Expanding coverage 
of these interventions for trans people is crucial within this system, but this 
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would not make a difference for trans people who are uninsured or 
underinsured. Without broad access to preventive, primary and specialty 
services, existing health care disparities, including those within trans and 
gender nonconforming populations along lines of race, class, geographic 
location and ability, will simply be exacerbated. Access to care for trans and 
gender-nonconforming people cannot be separated from the pressing need 
to increase access to healthcare in general.   
However, these are often viewed as unrelated issues. The very AMA that 
issued Resolution 122 has long been an opponent of restructuring the U.S. 
health system and universalizing healthcare. In comments submitted to the 
Senate Finance Committee, the AMA stated its position against establishing 
a public option: “The introduction of a new public plan threatens to restrict 
patient choice by driving out private insurers, which currently provide 
coverage for nearly 70 percent of Americans.”71 This opposition to 
universal healthcare or expanded health coverage in the public sector 
severely limits the capacity for increased equitability in health. A shift 
toward universal health coverage in the United States could be a move in 
the direction of reducing or eliminating a variety of health disparities both 
within and outside of trans and gender-nonconforming communities that 
stem from lack of access to affordable, high-quality healthcare. At the same 
time, universal health coverage without trans healthcare could worsen 
current health outcomes in trans and gender-nonconforming populations. 
And trans health care without universal coverage will only meet the needs 
of a limited set of people within these populations. Health and policy 
research must investigate and propose means to ensure that these 
discussions about universal access and trans health advocacy proceed in 
tandem, and to ensure that trans health is understood as legitimate within a 
context of a universal healthcare system. 
This section has explored how current foci of trans health research on 
interpersonal violence and HIV/AIDS has tended to garner more attention 
than other urgent issues, such as institutional violence and health policy 
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research on expansion of health coverage, to name just two examples. This 
is not to imply that HIV/AIDS and interpersonal violence are not real and 
important issues in trans and gender-nonconforming communities. They 
are, and these topics certainly warrant attention, consideration, and the 
development of strategies for reduction. However, claims that are made in 
the context of health research may obscure the ways in which other 
overlapping factors, such as experiences of racism, sexism, misdistribution 
of wealth, and so on, may increase the likelihood of individuals in trans and 
gender-nonconforming communities to encounter these issues.72 For 
example, lack of access to education or employment (often in the context of 
racism, classism, and sexism) might increase a trans individual’s 
vulnerability to homelessness. Gender-segregated shelter systems often 
refuse to house trans individuals based on gender identity or expression, and 
they also frequently enforce gendered dress codes or appearance.73 In 
addition, homelessness increases the likelihood that trans people will 
experience interpersonal violence and institutional violence through 
profiling and detention or arrest. 
The focus on experiences of disease, rather than shared, parallel, or 
interlocking experiences of marginalization74 within and beyond the context 
of these communities, may serve to divert attention away from some of the 
underlying causes of such diseases or barriers to health. Health research, in 
this case, may be less productive in the form of large-scale dataset analysis 
and more productive as a set of community-engaged projects to identify and 
interrogate health barriers and develop initiatives that target the root causes 
of these barriers. This would likely make a more tangible and beneficial 
difference in the lives of trans and gender-nonconforming people than many 
of the current uses of large-scale epidemiological research projects, which 
are more apt to fuel policy decisions by the state that penalize transgender 
people for experiencing health outcomes as a consequence of social 
inequities. Alternatively, if large-scale epidemiological research projects 
could significantly grow their capacity to take up questions of social 
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inequities and social embeddedness, this research strategy coupled with 
findings from local community-engaged research projects, could do a great 
deal to influence policy more effectively.  
IV. WHAT IS AT STAKE IN THE ACT OF RESEARCH INCLUSION? 
To best foster and support the health of trans and gender-nonconforming 
communities, it is important that we understand the health-related issues 
that affect us and how we increase access and reduce barriers to healthcare. 
Health research may play an important role in this. However, it is important, 
before we issue an unconditional call for inclusion in research programs, to 
consider the hazards of certain approaches to health research. In this 
section, I will discuss some of the challenges of researching trans health in 
the context of transgender as a medicalized identity. I will also discuss some 
of the pitfalls of epidemiologic approaches, such as the dangers of 
surveillance, the problems with reductive categories of identity, and the 
ways in which health research may play a part in exacerbating 
marginalization.   
In Inclusion: The Politics of Difference in Medical Research, Steven 
Epstein discusses the recent emergence in biomedical and pharmacological 
research of the “inclusion-and-difference” model.75 He uses this term to 
describe the paradigmatic shift away from “one-size-fits-all” assumptions 
about population health and toward a notion of “special populations” that 
require inclusion (of women, of people of color, of children, and so on) in 
research and that warrant a particular scrutiny within research that takes 
these “differences” into account. Epstein critiques some of the ways in 
which these formations concretize and reify culturally-informed notions of 
difference as fundamental, essential, and biologically based.76 
This reification and “biologization” of categories is particularly troubling 
because it simultaneously erases the sociopolitical context of identity and 
marginalization, and it also attempts to extract categories of identity and 
experience as independent and more or less separable variables.77 Janet 
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Shim discusses the divergent conceptions of race held by people with 
cardiovascular disease (CVD) and epidemiologists studying this disease. On 
one hand, people of color with CVD described racial identities as 
intertwined and inseparable from other categories of lived experience and 
identity. On the other hand, epidemiologists found this inseparability to be 
scientifically problematic: 
The epidemiologists I interviewed . . . view the fluidity and 
sensitivity of racial categories to social and political forces as 
scientifically troubling—categories can appear, disappear, and 
change meaning in response to the vicissitudes of the social, 
cultural, and political moment. In epidemiology, demographic 
variables are most conveniently managed and least subject to 
measurement error or bias when they are stable and constant, and 
therefore replicable and comparable over time and from study to 
study.78  
Given the ways in which race, class, and various other factors 
contextualize the experiences and barriers to heath of trans and gender-
nonconforming people, it is unlikely that rich or meaningful conclusions 
about health status may be reached by attempting to extract each of these 
(and others) into a series of stable, independent variables. The “difference-
and-inclusion” paradigm relies on these reductive notions of identity that 
fail to incorporate intersectional aspects of human experience and lived 
social realities.79 
Further, as has been observed in non-trans gay, bisexual, and queer men’s 
health advocacy, the centrality with which HIV/AIDS came to define GBQ 
men’s health came at the cost of establishing broad and multi-layered 
notions of health and wellbeing in these communities.80 Ideally, conducting 
research in concert with developing broad intersectional social and political 
projects will allow us to begin to document and establish discrepant barriers 
to access, and to highlight harms facing trans and gender-nonconforming 
populations. 
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Some researchers, such as those in social epidemiology or other types of 
research that value community engagement research, grapple with the social 
context and intersectionality of identity in approaching health research.81 
When discussing the process of defining “lesbian” for the sake of research, 
Marj Plumb argues that “until we know who ‘we’ are, it is going to be 
difficult, and rife with inaccuracy, to count us.”81 In fact, it is difficult to 
imagine a way to define “transgender” in the context of health research that 
would not be “rife with inaccuracy” and would not likely reinscribe 
divisions of relative privilege within trans and gender-nonconforming 
populations. Other modes of categorization or inquiry might capture 
important themes without organizing along lines of identity—for example, 
using qualitative in addition to quantitative methods, or structuring 
epidemiological investigations that begin “with lay observations of health 
effects.”82  
A second problem with enthusiastic endorsement of inclusion in health 
research is the issue of medicalization. This involves the ways in which 
medicine and medical expertise, in concert with law- and policymaking, 
take on the management of certain conditions, experiences, or identities.83 
Epstein discusses the ways in which activists have inadvertently become 
complicit in the medicalization of LGBQ and trans identities by making 
arguments for the validity of LGBT health. 
The likely consequence of the association of health risk with identity 
categories (rather than with shared practices or shared oppression) is the 
reification and medicalization of those identities. This might not be so 
worrisome were it not for the long history within medicine of 
conceptualizing difference as pathology.84 
For trans people in particular, this may be perilous territory because the 
very consolidation of trans identity as a medicalized identity may increase 
perceived legitimacy and access for those of us who access or want access 
to medical interventions to achieve our desired gender expression. 
However, this frequently comes at the expense of our own self-
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determination and at the expense of options available to those trans 
individuals (who are likely the majority) that do not want or who cannot 
afford surgeries to realize a desired gender expression. Legal recognition 
and support in accessing fair treatment, services, or benefits, for example, is 
frequently limited to trans individuals who have identities consistent with a 
medical model through surgeries or other medical intervention.85 
For some trans individuals, medicalization does ground identification 
with the category, but the degree to which this is true varies enormously. 
Further, we have already seen the ways in which pervasive medicalization 
has caused enormous damage to trans and gender-nonconforming 
individuals. Many policies that govern a person’s recognition as trans for 
purposes of various government agencies require medical evidence of 
having had gender-affirming surgeries, even though these are not necessary 
or affordable for many or most trans individuals.86 In addition, if surgeries 
are desired, individuals must comply with a long and complex set of 
psychiatric and medical evaluations and expectations to gain access.87 Upon 
completion of these, trans individuals may access costly surgery. However, 
since many insurance policies do not broadly cover such procedures at this 
point, trans individuals must pay for these treatments out-of-pocket, 
meaning that most people cannot access them. While the question of 
medicalization differs somewhat for trans and gender-nonconforming 
individuals than for LGBQ individuals, there is still a great stake in 
establishing relationships with biomedical establishments that begin from a 
point of self-determination rather than coercion. So long as health, 
epidemiologic, and pharmacologic research takes for granted the process by 
which trans and gender-nonconforming people are positioned within 
biomedicine, these important sources of ill health will not enter or be 
analyzed within the body of knowledge dealing with the health and 
wellbeing of trans and gender-nonconforming communities. 
A third caution when considering trans inclusion in research concerns the 
very practice of “counting” trans and gender-nonconforming individuals 
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and quantifying disease burdens within this group. A variety of scholars 
have argued that statistical data gathering is an instrument of population 
management. As Ian Hacking argues, statistics are grounded in “the notion 
that one can improve—control—a deviant subpopulation by enumeration 
and classification.”88 
Deborah Lupton paraphrases Michel Foucault in discussing the 
emergence of “medico-administrative” knowledge. Medicine, she writes:  
[B]ecame a “general technique of health” and not simply a means 
of ministering to or curing the ill. Medicine was enfolded within a 
system of administration, rendered part of the machinery of power, 
serving as the core of the “social economy.” As part of these 
changes, “population” becomes constituted as a problem, a target 
for surveillance, regulation, analysis, and intervention.”89  
In combination with medicine’s historical pathologization of difference, 
these histories offer a cautionary message about the potential consequences 
of pursuing health-based surveillance of trans communities. 
Finally, the last question to consider is the ways in which, particularly 
with regard to state-based health research, inclusion in research is tied to a 
notion of citizenship (this has been referred to as “biomedical” or 
“biopolitical” citizenship).90 The liberal, rights-based strategies that national 
LGBTQ organizations have taken on in the last decade as priorities and 
which center on legislative campaigns and foreground issues such as gay 
marriage, hate crimes legislation, and inclusion in the military have been 
critiqued for their move toward incorporation within, rather than resistance 
to, state-sanctioned institutions.91 LGBTQ health advocacy has, in large 
part, paralleled this, departing from the previous distrust with which federal 
institutions such as the DHHS, the NIH, and the CDC were viewed, there is 
now an urgent call to be considered, incorporated by and studied by these 
institutions. Once again, given the ways in which state-based institutions 
have been severe sources of coercion and violence for trans and gender-
nonconforming communities, an overreaching and uncritical desire for 
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incorporation within this biomedical framework should be considered 
suspect. 
Some health and epidemiologic researchers have called into question 
both the drive toward incorporation and the validity of the 
“expert/layperson” divide. Community-based participatory research 
(CBPR), an orientation toward research that values non-academic 
community members as instrumental to framing research questions, 
conducting research, and disseminating findings92 have been used in a 
variety of health studies to establish understanding of local knowledge93 
about health and wellbeing. Duran and Wallerstein discuss some of the 
ways in which research with this orientation may resist pervasive 
assumptions about traditional health and epidemiologic research: CBPR is 
“openly emancipatory research, which challenges the colonizing practices 
of positivist research and political domination by the elites.”94 Several 
important studies, some of which are ongoing,95 have taken this approach to 
health research. This may be a productive site for future investigations of 
health disparities within these communities that transcend those constrained 
by state-based agendas. 
As with the AMA resolution, some kinds of health research may help to 
generate more options for trans people. In continuing this work, however, it 
is critical to consider the ways in which benefits will or will not be 
equitably distributed across trans and gender-nonconforming communities. 
Departing from the dominant health research agendas of the state might 
present a set of different challenges, but it might enable us to document a 
broader and more comprehensive understanding of the factors underpinning 
trans and gender-nonconforming health in the United States. 
V. HEALTH RESEARCH AND “LOOPING EFFECTS” 
Another consideration in evaluating trans inclusion in research—albeit a 
slightly more abstract one—is how people respond to the ways in which 
they are categorized. Ian Hacking comments that 
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[W]e tend to behave in the ways that are expected of us, especially 
by authority figures—doctors, for example. . . . People classified in 
a certain way tend to conform to or grow into the ways that they 
are described; but they also evolve in their own ways, so that the 
classifications and descriptions have to be constantly revised.96 
This matters because health research plays a part in the way we, as trans 
and gender-nonconforming people, see ourselves. Although this is not, as 
Hacking importantly emphasizes, a one-way street, it is significant to 
examine the ways in which medicine and research contextualize—and in 
some ways define—our identities and experiences. 
The concept of invisibility and erasure are consistent themes in the lives 
of many transgender and gender-nonconforming individuals, and the case of 
health is no exception. As part of the Trans PULSE community-based 
research project out of Ontario, Canada, researchers found that a particular 
theme that arose in qualitative research with trans community members 
about perceived barriers to health was the concept of “informational and 
institutional erasure.”97 This was reflected by institutions viewing trans 
health as anomalous and placing the onus of system navigation on trans 
individuals. Qualitative data reflected frustration with the lack of 
knowledge on the part of healthcare providers about the existence and needs 
of trans and gender-nonconforming individuals (informational erasure) and 
a lack of policies and documents, such as medical intake forms, that listed 
or acknowledged the possibility of trans and gender-nonconforming patients 
accessing services (institutional erasure).98 Notably, while this research 
project holds in common certain findings as some of the needs assessments, 
it has uncovered a slightly different set of priorities than many health 
studies that concern trans and gender-nonconforming communities. It 
emphasizes administrative changes over formal legal changes, which 
departs from the standard rubric of state-based LGBTQ health.99 In 
addition, in its qualitative methodological approach, it attends to the range 
of different needs that span trans and gender-nonconforming communities 
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and captures information about the lived realities of trans and gender-
nonconforming individuals grappling with a concept of health and wellness 
through gender non-normative positionalities.100 
Interestingly, the Trans PULSE study has also captured some of the ways 
in which trans people conceptualize themselves in and through research. In 
discussing informational erasure, which the authors argue includes the lack 
of research findings, one participant commented, “I’m one of the dead ones. 
Remember [this], just because you’re [transsexual], you’re one of the dead 
ones. All of this time that I’ve survived, I’m one of the walking dead 
because we’re not counted; we’re not represented anywhere.”101 This is 
quite a profound indication of the ways in which health research, healthcare 
delivery, medicalization, professionalization, political marginalization, and 
other factors have interacted to tether identity to surveillance, research, and 
representation.   
Ian Hacking discusses the “looping effects of human kinds.”102 He more 
recently has referred to these as “interactive” kinds (contrasted with 
“indifferent” kinds).103 He describes looping effects as the ways in which 
“human beings and human acts come into being hand in hand with our 
invention of the categories of labeling them.”104 These effects, he argues, 
come “from above” (or from experts who name and categorize humans) as 
well as “from below” (from those who are being named and categorized). In 
a variety of ways, this “conversation” can be observed within trans and 
gender-nonconforming communities to occur in the very negotiation of 
naming: even in the choice to spell “transexual” with a single “s.” However, 
it seems that increasingly, trans and gender-nonconforming individuals are 
positioning ourselves within this conversation inside a framework of 
recognition and inclusion, and research seems not to be an exception. 
Further, in understanding ourselves in and through bodies of traditional 
health and epidemiologic research, are we in danger of reducing our notion 
of ourselves, our health, and our wellbeing to disease risk and susceptibility 
to violence? Are we invoking a desire for better and nicer experts to manage 
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our existences and identities, or are we calling for a broader authority and 
weight of local and community-based knowledge? What is at stake in 
connecting the validation of existence to health surveillance? Are there 
ways that we might pursue knowledge about health and wellbeing in trans 
communities that is broader, more expansive, less tied to state interests, and 
more transformative in its potential for action and change? If so, how might 
we position our communities, inclusive and cognizant of the marked 
differences within them, to leverage our significant resilience and strength 
to gather this knowledge and find solutions to the issues that compromise 
and endanger our health and wellbeing? 
CONCLUSION 
Trans and gender-nonconforming people are clearly in need of better 
quality, more comprehensive, more affordable, and more supportive 
healthcare. A variety of factors, including biomedicine’s reliance on 
evidence-based medicine in establishing public and private insurance 
coverage policies have made research an important pursuit. But a myopic 
and single-minded pursuit of health and epidemiologic research on trans 
and gender-nonconforming communities fails to take into account a number 
of important considerations. 
First, there may be broader and more expansive ways to obtain these 
necessary changes, as through the transformation of the health system to 
provide universal access to healthcare inclusive of just and supportive 
gender-affirming care. Second, while health research itself is not a bad idea, 
a variety of features of the current frameworks of research (especially state-
based research) invite thorough consideration of how trans and gender-
nonconforming communities want to position ourselves within these 
frameworks. Third, if we continue to call for health and epidemiologic 
research within our communities, it will be crucial to attend to the ways in 
which relative access to privilege varies radically and to recognize that 
these differences profoundly shape health disparities within our 
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communities. Last, as we consider what changes in the status quo will 
improve health and wellbeing for trans and gender-nonconforming 
individuals, it is important to reflect on what is at stake in any of the courses 
of action that we may choose to take. Health research may be a component 
of this, but a departure from the course that LGBTQ health activism has 
taken will probably be of great benefit in the long run. Community 
engagement and local knowledge will likely strengthen and deepen the 
body of knowledge that we build with regard to health, and these are more 
likely to productively shape and mesh with existing community-based 
movements. 
Let us develop ways to pursue health research that do not leave gaps in 
what we are permitted to know about ourselves. We will not gain access to 
knowledge that is sufficiently rich or robust if we only enlist “experts” to 
develop this knowledge and align ourselves with state agendas. An 
overreliance on professionalized expertise and state-based alignment will 
create a situation in which we are even less likely to attend to some of the 
central factors compromising health in trans and gender-nonconforming 
communities. Community-based participatory research is one way to 
structure research programs in a more inclusive and productive way. 
Developing and strengthening grassroots and community-based groups that 
are doing work that overlaps with or within trans and gender-
nonconforming communities will help us continue to build on and share 
local knowledge and to create alliances with overlapping communities that 
may share similar barriers to health (individuals with disabilities, people of 
color, low-income people, etc.). 
Although it is profoundly painful and frustrating to witness the continued 
marginalization of trans health within larger LGBTQ health advocacy, we 
may have been granted an opportunity to take a different direction in 
gathering knowledge and setting a distinct course in the pursuit of our 
health and wellbeing. Let us hope that our example will inspire others to 
follow. 
Counting Us In 571 
VOLUME 8 • ISSUE 2 • 2010 
 
                                                 
1 The author would like to extend special thanks to Elizabeth Payne and Dean Spade 
along with the editorial staff of the Seattle Journal for Social Justice. 
2 See, e.g., Jae Sevelius, “There’s No Pamphlet for the Kind of Sex I Have”: HIV-Related 
Risk Factors and Protective Behaviors Among Transgender Men Who Have Sex With 
Nontransgender Men, 20 J. ASS’N NURSES AIDS CARE, 335, 398 (2009); Joseph P. De 
Santis, HIV Infection Risk Factors Among Male-To-Female Transgender Persons: A 
Review of the Literature, 20 J. ASS’N NURSES AIDS CARE 335, 362 (2009); Jeffrey H. 
Herbst et al., Estimating HIV Prevalence and Risk Behaviors of Transgender Persons in 
the United States: A Systematic Review, 12 AIDS BEHAV. 1, 1 (2008); Emilia L. 
Lombardi et al., Gender Violence: Transgender Experiences With Violence and 
Discrimination, 42 J. HOMOSEXUALITY 1, 1 (2002). 
3 See generally IAN HACKING, The Looping Effect of Human Kinds, in CAUSAL 
COGNITION: A MULTIDISCIPLINARY DEBATE 351 (Dan Sperber et al. eds., 1995). 
4 JULIA SERANO, WHIPPING GIRL: A TRANSSEXUAL WOMAN ON SEXISM AND THE 
SCAPEGOATING OF FEMININITY 115 (2007); Karl Bryant, Making Gender Identity 
Disorder of Childhood: Historical Lessons for Contemporary Debates, 3 SEXUALITY 
RESEARCH AND SOC. POL’Y 23–29 (2006). 
5 George J. Wilkerson, What We Don’t Know: The Unaddressed Health Concerns of the 
Transgendered, TRANS-HEALTH, http://www.trans-health.com/displayarticle.php? 
aid=7 (last visited Feb. 19, 2010). 
6 Sevelius, De Santis, Herbst, Lombardi, supra note 1. Throughout the paper, I will 
employ the term “transgender,” “trans,” and “gender-nonconforming” to refer to 
individuals who vary from symmetrical arrangements of birth-assigned sex with 
dominant cultural expectations of gender expression. There is some necessary slippage 
and vagueness in the language here, which is the topic of many investigations about the 
category of “transgender” itself. See DAVID VALENTINE, IMAGINING TRANSGENDER: AN 
ETHNOGRAPHY OF A CATEGORY (2007) for one such exploration. As Valentine 
discusses, there is a tension within this term, as it is often externally applied to those who 
reject it or would not choose to apply it to themselves, as well as being a term that people 
use in various ways to self-identify. In addition, the inclusion of non-trans intersex people 
in the broad category “gender nonconforming” varies, depending greatly on the ways in 
which these individuals self-identify, seek services, or are extended membership by 
groups, organizations, and agencies. However, in the context of health research, there 
seems to be a fairly consistent divide between “transgender individuals” and “intersex 
individuals,” despite the potential overlaps of the two. 
7 “Transsexuals” is a term I use in the context of this article only to capture dominant 
language used by medical and psychiatric researchers during this time. This term 
continues to be used in a variety of ways, both within the field of research (although, it 
would seem, to a far lesser degree than previously) and by people in trans communities, 
in general. Many trans individuals themselves spell the term with one “s” to resist the 
pathologizing legacy of the word, while others claim the term “transsexual” but not 
“transgender.” VALENTINE, supra note 5 at 25–26. 
8 See generally HARRY BENJAMIN, THE TRANSSEXUAL PHENOMENON (1966). 
572 SEATTLE JOURNAL FOR SOCIAL JUSTICE 
TRANSGENDER ISSUES AND THE LAW 
 
9 M. HIRSCHFELD, DIE INTERSEXUELLE KONSTITUTION JAHRBUCH FUER SEXUELLE 
ZWISCHENSTUFEN 23 (1923). 
10 See, e.g., Greta R. Bauer et al., “I Don’t Think This Is Theoretical; This Is Our Lives”: 
How Erasure Impacts Health Care for Transgender People, 20 J. ASS’N NURSES AIDS 
CARE 335, 348 (2009); Kristin Clements-Nolle & Ari Max Bachrach, Community-Based 
Participatory Research With a Hidden Population: The Transgender Community Health 
Project, in COMMUNITY BASED PARTICIPATORY RESEARCH FOR HEALTH 332, 332 
(Meredith Minkler & Nina Wallerstein eds., 2002); Jessica M. Xavier et al., A Needs 
Assessment of Transgendered People of Color Living in Washington, D.C., 8 INT’L J. 
TRANSGENDERISM 1, 31 (2005). 
11 This is reflected both by the increased presence of trans and gender-nonconforming 
individuals who lead health research, but also by changes such as the recent inclusion of 
trans individuals on the board of bodies such as the World Professional Association for 
Transgender Health (WPATH, formerly the Harry Benjamin International Gender 
Dysphoria Association, or HBIGDA), that circulates the most broadly-circulated 
Standards of Care for trans patients seeking gender-related medical interventions. 
12 See, e.g., GIANNA E. ISRAEL & DONALD E. TARVER, TRANSGENDER CARE: 
RECOMMENDED GUIDELINES, PRACTICAL INFORMATION, AND PERSONAL ACCOUNTS 
(1997). 
13 I use ‘LGBT health’ when ‘queer’ is not necessarily specifically implied. Generally, I 
use “LGBTQ” to include queer-identified individuals, as well. Acronyms that are 
inclusive of two-spirit individuals, intersex individuals, individuals who identify as same-
gender-loving, people who are questioning their sexuality, and others are also frequently 
included in acronyms to generally describe these communities.  
14 Steven Epstein, Sexualizing Governance and Medicalizing Identities: The Emergence 
of ‘State-Centered’ LGBT Health Politics in the United States, 6 SEXUALITIES 135 
(2003). 
15 STEVEN EPSTEIN, IMPURE SCIENCE: AIDS, ACTIVISM, AND THE POLITICS OF 
KNOWLEDGE 32–33 (1996). 
16 Epstein, supra note 13, at 138–41. 
17 Id. at 139. 
18 Id. at 141. 
19 Id. 
20 For a discussion of health disparities as a frame in the context of discussions about 
health, see Nancy Krieger et al., Painting a Truer Picture of US Socioeconomic and 
Racial/Ethnic Health Inequalities: The Public Health Disparities Geocoding Project, 95 
AM. J. OF PUB. HEALTH 312 (2005). 
21 GAY AND LESBIAN MEDICAL ASS’N & LGBT HEALTH EXPERTS, HEALTHY PEOPLE 
2010 COMPANION DOCUMENT FOR LESBIAN, GAY, BISEXUAL, AND TRANSGENDER 
(LGBT) HEALTH (2001) [hereinafter 2010 COMPANION DOCUMENT FOR LGBT]. 
22 Epstein, supra note 13. 
23 Id. at 151. 
24 2010 COMPANION DOCUMENT FOR LGBT, supra note 20. 
25 Katherine L. Turner et al., Lesbian, Gay, Bisexual, and Transgender Cultural 
Competency for Public Health Practitioners, in THE HANDBOOK OF LESBIAN, GAY, 
Counting Us In 573 
VOLUME 8 • ISSUE 2 • 2010 
 
BISEXUAL, AND TRANSGENDER PUBLIC HEALTH: A PRACTITIONER’S GUIDE TO SERVICE 
59, 60 (Michael D. Shankle ed., 2006). 
26 Epstein, supra note 13, at 159. 
27 Id. 
28 Emily Douglas, An Uneasy Alliance, AM. PROSPECT, Nov., 2008, at 30. 
29 Id. 
30 Rickke Mananzala & Dean Spade, The Nonprofit Industrial Complex and Trans 
Resistance, 5 SEXUALITY RESEARCH & SOC. POL’Y 53, 53 (2008). 
31 JESSICA XAVIER ET AL., NATIONAL COALITION FOR LGBT HEALTH, AN OVERVIEW OF 
US TRANS HEALTH PRIORITIES: A REPORT BY THE ELIMINATING DISPARITIES WORKING 
GROUP (Aug., 2004), available at http://www.lgbthealth.net/downloads/ 
research/US_Trans_Health_Piorities.pdf. 
32 The World Health Organization defines global burden of disease to be a “time-based 
measure” that “combines years of life lost due to premature mortality and years of life 
lost due to time lived in states of less than full health.” World Health Organization, 
Global Burden of Disease, www.who.int/topics/global_burden_of_disease/en/ (last 
visited Feb. 17, 2010). 
33 XAVIER ET AL., supra note 31, at 3-4. 
34 XAVIER ET AL., supra note 31, at 3. 
35 XAVIER ET AL., supra note 31, at 3. 
36 See, e.g., WALTER BOCKTING & ERIC AVERY, TRANSGENDER HEALTH AND HIV 
PREVENTION: NEEDS ASSESSMENT STUDIES FROM TRANSGENDER COMMUNITIES 
ACROSS THE UNITED STATES (2005); Gretchen P. Kenagy, Transgender Health: 
Findings From Two Needs Assessment Studies in Philadelphia, 30 HEALTH & SOC. 
WORK 19, 19 (2005); Xavier, supra note 9. 
37 See generally 2010 COMPANION DOCUMENT FOR LGBT, supra note 20; XAVIER ET 
AL., supra note 31.   
38 See generally Meredith Minkler & Nina Wallerstein, Introduction to Community Based 
Participatory Research, in COMMUNITY BASED PARTICIPATORY RESEARCH FOR 
HEALTH, 3–5 (Meredith Minkler & Nina Wallerstein eds., 2002); Kristen Clements-Nolle 
et al., HIV Prevalence, Risk Behaviors, Health Care Use, and Mental Health Status of 
Transgender Persons: Implications for Public Health Intervention, 91 AM. J. PUB. 
HEALTH 915 (2001); Bauer et al., supra note 9. 
39 For example, the UCSF Center of Excellence on Transgender HIV prevention became 
the Center of Excellence in Transgender Health in 2009. The precise co-occurrence of 
HIV/AIDS epidemiologic research and transgender health is more complicated than may 
be attended to in the context of this article. It is, to the author’s knowledge, unclear 
whether HIV/AIDS prevention gained centrality as a topic because HIV/AIDS research 
has focused on marginalized groups, or because needs assessment studies repeatedly 
found such high incidence and prevalence rates of HIV/AIDS, as asserted in Xavier, 
supra note 9, and Bockting & Avery, supra note 36, that resources and attention have 
been consolidated in the arena. Regardless of the particularities, HIV/AIDS prevention 
and epidemiologic research is frequently intertwined with discussions of trans health. 
40 Ethan Jacobs, Collection of Trans HIV Data Slow, BAY WINDOWS ONLINE (June 26, 
2008), http://www.baywindows.com/index.php?ch=news&sc=glbt&sc2=news&sc3 
574 SEATTLE JOURNAL FOR SOCIAL JUSTICE 
TRANSGENDER ISSUES AND THE LAW 
 
=&id=76431; SAN FRANCISCO AIDS FOUNDATION, TRANSGENDER PERSONS AND HIV, 
HIV EVIDENCE REPORT (Jan. 2009), http://www.sfaf.org/files/site1/asset/sfaf-hiv-
evidence-report-jan-2009.pdf. 
41 Edward H. Kaplan & Michael H. Merson, Allocating HIV-Prevention Resources: 
Balancing Efficiency and Equity, 92 AM. J. PUB. HEALTH 1905 (2002). 
42 Jordan Blaza & Elizabeth Mediano, Asian Pacific AIDS Intervention Team, Los 
Angeles, CA, Transgender Program for Excellence: HIV Prevention and Community 
Education, Presentation at the 2003 National HIV Prevention Conference (July 28, 2003) 
(abstract available at http://gateway.nlm.nih.gov/MeetingAbstracts/ma?f=102262202. 
html) (focusing on M-T-F individuals). 
43 See, e.g., Rita M. Melendez & Rogerio M. Pinto, HIV Prevention and Primary Care 
for Transgender Women in a Community-Based Clinic, 20 J. ASS’N NURSES AIDS CARE, 
335, 387 (2009); see generally BOCKTING & AVERY, supra note 36; De Santis, supra 
note 1; Kenagy, supra note 36; Sari Resiner et. al., HIV Risk and Social Networks Among 
Male-to-Female Transgender Sex Workers in Boston, Massachusetts, 20 J. ASS’N OF 
NURSES AIDS CARE 373 (2009). 
44 Clements-Nolle & Bachrach, supra note 9. 
45 See, e.g., Bauer et al., supra note 9; Clements-Nolle & Bachrach, supra note 9. 
46 INCITE! WOMEN OF COLOR AGAINST VIOLENCE, THE REVOLUTION WILL NOT BE 
FUNDED: BEYOND THE NON-PROFIT INDUSTRIAL COMPLEX 1–8 (2007). 
47 JENNIFER R. WOLCH, THE SHADOW STATE: GOVERNMENT AND VOLUNTARY SECTOR 
IN TRANSITION (1990). 
48 INCITE!, supra note 46, at 8–9. 
49 Ruth Gilmore, In the Shadow of the Shadow State, in THE REVOLUTION WILL NOT BE 
FUNDED: BEYOND THE NON-PROFIT INDUSTRIAL COMPLEX 49 (Incite! Women of Color 
Against Violence eds., 2007) (discussing the Pacifica Radio being a listener-sponsored 
organization that created a national board under the pressures to “professionalize”); Alisa 
Bierria, Pursuing a Radical Anti-Violence Agenda Inside/Outside a Non-Profit Structure, 
in THE REVOLUTION WILL NOT BE FUNDED: BEYOND THE NON-PROFIT INDUSTRIAL 
COMPLEX 151 (Incite! Women of Color Against Violence eds., 2007). 
50 Gilmore, supra note 49, at 47. 
51 See Lisa Duggan, THE TWILIGHT OF EQUALITY?: NEOLIBERALISM, CULTURAL 
POLITICS, AND THE ATTACK ON DEMOCRACY at xvii–xx, 9–11 (2003).  
52 Mananzala & Spade, supra note 29, at 55–56. 
53 STEVEN EPSTEIN, INCLUSION: THE POLITICS OF DIFFERENCE IN MEDICAL RESEARCH 
264 (2007). 
54 Removing Financial Barriers to Care for Transgender Patients: Hearing on Res. 122 
Before the American Medical Association H.D. (2008). It is important to note that prior to 
acceptance of this resolution, the AMA House of Delegates decided on Resolution 122 
Removing Financial Barriers to Care for Transgender Patients, rather than Resolution 114 
Removing Barriers to Care for Transgender Patients, or Resolution 115 Removing 
Insurance Barriers to Care for Transgender Patients. In addition, amendments were made 
to the resolution to include language stipulating physicians’ involvement in the 
assessment and determination of treatment of gender identity disorder. 
55 This navigation is required of trans and gender-nonconforming people whether or not 
they desire gender-confirming medical intervention, as those who do not must still access 
Counting Us In 575 
VOLUME 8 • ISSUE 2 • 2010 
 
primary care or attempt to get a legal identification, for example, in a system that is 
reliant on a medicalized proof of identity. 
56 XAVIER, supra note 31, at 2. 
57 Dean Spade, Transformation: Three Myths Regarding Transgender Identity Have Led 
to Conflicting Laws and Policies that Adversely Affect Transgender People, 31 L.A. 
LAWYER 38–39 (2008). 
58 Walter Bockting, Transgender HIV Prevention: A Qualitative Needs Assessment, 10 
AIDS CARE 505–25 (1998); see generally Kenagy, supra note 36; Xavier et al., supra 
note 9. 
59 For example, the high HIV incidence and prevalence rates that smaller-scale studies 
have found have been used to justify a need to fund and create transgender-specific HIV 
prevention and programming. See, e.g., Jae Sevelius et al., Center for Excellence for 
Transgender HIV Prevention, Serving Transgender People in California: Assessing 
Progress, Advancing Excellence 8 (2008), http://transhealth.ucsf.edu/pdf/serving-trans-
ca.pdf. 
60 See generally VALENTINE, supra note 5. 
61 Nancy Krieger, Questioning Epidemiology: Objectivity, Advocacy, and Socially 
Responsible Science, 89 AM. J. PUB. HEALTH 1151, 1152 (1999). 
62 Marj Plumb, Undercounts and Overstatements: Will the IOM Report on Lesbian 
Health Improve Research?, 91 AM. J. PUB. HEALTH, 873, 874 (2001). 
63 DEBORAH LUPTON, RISK 99 (1999). 
64 EPSTEIN, supra note 53, at 291. 
65 U.S. Food and Drug Administration, Blood Donations from Men Who Have Sex with 
Other Men Questions and Answers, http://www.fda.gov/biologicsbloodvaccines/ 
bloodbloodproducts/questionsaboutblood/ucm108186.htm (last visited Mar. 4, 2010). 
66 There are some exceptions to this, some of which I discuss later in the context of 
community-based research. Generally, trans health research, particularly as it is 
positioned within broader LGBTQ health activism agendas, largely fails to engage with 
these, or does so in a way that presumes “competency” issues are at the root rather than 
structural ones. 
67 A search in PubMed, http://www.nci.nlm.nih.gov/pubmed, yielded ninety-eight results 
for the concurrent terms “transgender” and “HIV” in the title or abstract of articles. 
Another search yielded twenty-seven results for “transgender” and “violence.” Of these 
twenty-seven, abstracts generally described “violence” as “domestic violence,” “sexual 
violence,” “intimate partner violence,” “harassment and discrimination,” “assaults,” 
“violence in their homes,” and others. While at least some of these did not necessarily 
exclude the described acts of violence from occurring in an institutional setting, very few 
made explicit mention of state employees or institutions, and none made explicit mention 
of institutional violence or violence by police, prison staff, group home staff and so on. 
68 INCITE! WOMEN OF COLOR AGAINST VIOLENCE, LAW ENFORCEMENT VIOLENCE 
AGAINST WOMEN OF COLOR & TRANSGENDER PEOPLE OF COLOR: A CRITICAL 
INTERSECTION OF GENDER VIOLENCE & STATE VIOLENCE 25-28, available at 
http://www.incite-national.org/media/docs/3696_TOOLKIT-FINAL.pdf.  
69 Matthew Shepard Hate Crimes Prevention Act Clears Key Senate Hurdle, HUMAN 
RIGHTS CAMPAIGN, July 16, 2009, http://www.hrc.org/13187.htm. 
576 SEATTLE JOURNAL FOR SOCIAL JUSTICE 
TRANSGENDER ISSUES AND THE LAW 
 
70 blackandpink.org: A Compilation of Critiques on Hate Crimes Legislation, 
http://www.blackandpink.org/revolt/a-compilation-of-critiques-on-hate-crimes-
legislation/ (last visited Feb. 19, 2010). 
71 Robert Pear, Doctors’ Group Opposes Public Insurance Plan, N.Y. TIMES, June 11, 
2009, at A11. 
72 See generally Mananzala & Spade, supra note 29. 
73 LISA MOTTET & JOHN OHLE, NAT’L GAY AND LESBIAN TASK FORCE POL’Y INST., 
TRANSITIONING OUR SHELTERS 32–34 (2003). 
74 EPSTEIN, supra note 53, at 270. 
75 Id. at 17. 
76 Id. at 293–96. 
77 See Janet K. Shim, Constructing Race Across the Science-Lay Divide: Racial 
Formation in the Epidemiology and Experience of Cardio Vascular Disease, 35 SOC. 
STUD. SCI. 405, 412 (2005). 
78 See id. 
79 See generally Kimberle Crenshaw, Mapping the Margains: Intersectionality Identity 
Politics and Violence Against Women of Color, in THE PUBLIC NATURE OF PRIVATE 
VIOLENCE 93 (Martha Fineman & Roxanne Mykitiuk eds., 1994); EPSTEIN, supra note 
53. 
80 EPSTEIN, supra note 53. 
81 See Lisa F. Berkman &  Ichiro Kawachi, A Historical Framework for Social 
Epidemiology, in SOCIAL EPIDEMIOLOGY 3, 7–8 (Lisa F. Berkman & Ichiro Kawachi 
eds., 2000); N. Krieger, A Glossary for Social Epidemiology, 55 J. EPIDEMIOLOGY AND 
COMMUNITY HEALTH 693, 695–99 (2001); Ana V. Diez-Roux, Bringing Context Back 
Into Epidemiology: Variables and Fallacies in Multilevel Analysis, 88 AM. J. PUB. 
HEALTH 216, 216–17 (1998); Margaret W. Leung et al., Community-Based Participatory 
Research: A Promising Approach for Increasing Epidemiology’s Relevance in the 21st 
Century, 33 INT’L J. EPIDEMIOLOGY 499, 499–504 (2004). 
81 Plumb, supra note 63, at 874. 
82 Leung et al., supra note 82, at 502. 
83 Medicalization and de-medicalization are frequent themes in the sociology of health 
and medicine. See PETER CONRAD, THE MEDICALIZATION OF SOCIETY: ON THE 
TRANSFORMATION OF HUMAN CONDITIONS INTO TREATABLE 4 (2007). However, a 
variety of interesting critiques of an orthodox concept of “medicalization” as a critique 
have arisen in the last decade. Deborah Lupton, Foucault and the Medicalisation 
Critique, in FOUCAULT, HEALTH AND MEDICINE 94–97 (Alan Petersen & Robin Bunton 
eds., 1997); Nikolas Rose, Beyond Medicalisation, 369 LANCET 700, 700–02 (2007). 
Although I will not explore these themes in this essay, these explore compelling themes 
in complicating a critique of the role of medicine beyond a concept of “medicalization,” 
and in doing so emphasize the futility of “de-medicalization” as a pursuit, and consider 
the active and significant role of the patient in returning the clinical gaze. Regardless of 
these critiques, for the purposes of this paper, I use the term “medicalization” to critique 
the role of medicine in its coercive and restrictive management of gender nonconformity. 
84 Epstein, supra note 13, at 160. 
85 Dean Spade, Compliance is Gendered: Struggling for Gender Self-Determination in a 
Hostile Economy, in TRANSGENDER RIGHTS 229 (Paisley Currah et al. eds.) (2006). 
Counting Us In 577 
VOLUME 8 • ISSUE 2 • 2010 
 
86 Spade, supra note 57, at 37–38. 
87 THE HARRY BENJAMIN INTERNATIONAL GENDER DYSPHORIA ASSOCIATION’S 
STANDARDS OF CARE FOR GENDER IDENTITY DISORDERS 20–21 (6th ed. 2001). 
88 IAN HACKING, THE TAMING OF CHANCE 3 (1990). 
89 DEBORAH LUPTON, THE IMPERATIVE OF HEALTH: PUBLIC HEALTH AND THE 
REGULATED BODY 23 (quoting MICHEL FOUCAULT, The Politics of Health In the 
Eighteen Century, in THE FOUCAULT READER 278 (Pantheon Books 1984)). 
90 NIKOLAS ROSE, THE POLITICS OF LIFE ITSELF: BIOMEDICINE, POWER, AND 
SUBJECTIVITY IN THE TWENTY-FIRST CENTURY 146 (2007); EPSTEIN, supra note 53, at 
21. 
91 See generally TRANSGENDER RIGHTS (Paisley Currah et al. eds.) (2006); Manazala & 
Spade, supra note 29. 
92 See, e.g., Clements-Nolle & Bachrach, supra note 9. 
93 Various definitions of “local knowledge” exist. Lindblom and Cohen describe a 
“knowledge that does not owe its origin, testing, degree of verification, truth status, or 
currency to distinctive . . . professional techniques but rather to common sense, casual 
empiricism, or thoughtful speculation and analysis.” CHARLES E. LINDBLOM & DAVID K. 
COHEN, USABLE KNOWLEDGE: SOCIAL SCIENCE AND SOCIAL PROBLEM SOLVING 12 
(1979). 
94 Minkler & Wallerstein, supra note 38, at 28. 
95 See, e.g., Bauer et al., supra note 9; Clements-Nolle & Bachrach, supra note 9. 
96 IAN HACKING, REWRITING THE SOUL: MULTIPLE PERSONALITY AND THE SCIENCES OF 
MEMORY 21 (1995). 
97 Bauer et al., supra note 9, at 356. 
98 Id. at 352–56. 
99 Id. at 357–59. 
100 Id. 
101 Id. at 352. 
102 See HACKING, supra note 2. 
103 IAN HACKING, THE SOCIAL CONSTRUCTION OF WHAT? 103–06 (1999). 
104 Ian Hacking, Making Up People, in THE SCIENCE STUDIES READER 161, 170 (Mario 
Biagioli ed., 1999). 
